Načítá se...
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
The German Psoriasis Registry PsoBest was conducted in 2008 in order to investigate the long-term outcomes and safety of systemic treatments for moderate-to-severe psoriasis. Safety analysis of antipsoriatic drugs with special focus on serious adverse events (SAE) for infections, malignancies and ma...
Uloženo v:
| Vydáno v: | Arch Dermatol Res |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4643107/ https://ncbi.nlm.nih.gov/pubmed/26358263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00403-015-1593-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|